CARETRUST REIT INC (CTRE)

US14174T1079 - REIT

27.36  +0.15 (+0.55%)

After market: 27.5 +0.14 (+0.51%)

Fundamental Rating

6

CTRE gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 130 industry peers in the Diversified REITs industry. While CTRE has a great profitability rating, there are some minor concerns on its financial health. CTRE is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make CTRE suitable for growth investing!



7

1. Profitability

1.1 Basic Checks

CTRE had positive earnings in the past year.
In the past year CTRE had a positive cash flow from operations.
CTRE had positive earnings in 4 of the past 5 years.
In the past 5 years CTRE always reported a positive cash flow from operatings.

1.2 Ratios

CTRE has a Return On Assets of 3.38%. This is amongst the best in the industry. CTRE outperforms 82.81% of its industry peers.
The Return On Equity of CTRE (4.08%) is better than 64.84% of its industry peers.
With an excellent Return On Invested Capital value of 4.92%, CTRE belongs to the best of the industry, outperforming 90.63% of the companies in the same industry.
CTRE had an Average Return On Invested Capital over the past 3 years of 5.48%. This is above the industry average of 3.08%.
Industry RankSector Rank
ROA 3.38%
ROE 4.08%
ROIC 4.92%
ROA(3y)2.14%
ROA(5y)2.96%
ROE(3y)3.55%
ROE(5y)4.89%
ROIC(3y)5.48%
ROIC(5y)5.38%

1.3 Margins

CTRE's Profit Margin of 36.73% is amongst the best of the industry. CTRE outperforms 88.28% of its industry peers.
CTRE's Profit Margin has declined in the last couple of years.
The Operating Margin of CTRE (65.34%) is better than 99.22% of its industry peers.
CTRE's Operating Margin has improved in the last couple of years.
The Gross Margin of CTRE (98.16%) is better than 98.44% of its industry peers.
Industry RankSector Rank
OM 65.34%
PM (TTM) 36.73%
GM 98.16%
OM growth 3Y1.9%
OM growth 5Y3.08%
PM growth 3Y-18.48%
PM growth 5Y-7.78%
GM growth 3YN/A
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CTRE is destroying value.
The number of shares outstanding for CTRE has been increased compared to 1 year ago.
Compared to 5 years ago, CTRE has more shares outstanding
The debt/assets ratio for CTRE has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 6.32 indicates that CTRE is not in any danger for bankruptcy at the moment.
CTRE's Altman-Z score of 6.32 is amongst the best of the industry. CTRE outperforms 99.22% of its industry peers.
CTRE has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
CTRE has a better Debt to Equity ratio (0.16) than 97.66% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 6.32
ROIC/WACC0.57
WACC8.66%

2.3 Liquidity

A Current Ratio of 4.14 indicates that CTRE has no problem at all paying its short term obligations.
CTRE has a better Current ratio (4.14) than 91.41% of its industry peers.
A Quick Ratio of 4.14 indicates that CTRE has no problem at all paying its short term obligations.
CTRE's Quick ratio of 4.14 is amongst the best of the industry. CTRE outperforms 91.41% of its industry peers.
Industry RankSector Rank
Current Ratio 4.14
Quick Ratio 4.14

7

3. Growth

3.1 Past

CTRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 75.61%, which is quite impressive.
The Earnings Per Share has been decreasing by -7.79% on average over the past years.
CTRE shows a strong growth in Revenue. In the last year, the Revenue has grown by 28.22%.
CTRE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.78% yearly.
EPS 1Y (TTM)75.61%
EPS 3Y-17.34%
EPS 5Y-7.79%
EPS Q2Q%162.5%
Revenue 1Y (TTM)28.22%
Revenue growth 3Y6.89%
Revenue growth 5Y6.78%
Sales Q2Q%38.48%

3.2 Future

Based on estimates for the next years, CTRE will show a very strong growth in Earnings Per Share. The EPS will grow by 45.40% on average per year.
Based on estimates for the next years, CTRE will show a quite strong growth in Revenue. The Revenue will grow by 18.92% on average per year.
EPS Next Y77.44%
EPS Next 2Y69.27%
EPS Next 3Y45.4%
EPS Next 5YN/A
Revenue Next Year14.39%
Revenue Next 2Y18.33%
Revenue Next 3Y18.92%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 38.00, the valuation of CTRE can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as CTRE.
The average S&P500 Price/Earnings ratio is at 27.20. CTRE is valued slightly more expensive when compared to this.
CTRE is valuated rather expensively with a Price/Forward Earnings ratio of 19.89.
Based on the Price/Forward Earnings ratio, CTRE is valued cheaper than 91.41% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.73, CTRE is valued at the same level.
Industry RankSector Rank
PE 38
Fwd PE 19.89

4.2 Price Multiples

89.84% of the companies in the same industry are cheaper than CTRE, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 22.29

4.3 Compensation for Growth

CTRE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CTRE has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CTRE's earnings are expected to grow with 45.40% in the coming years.
PEG (NY)0.49
PEG (5Y)N/A
EPS Next 2Y69.27%
EPS Next 3Y45.4%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.26%, CTRE is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 16.05, CTRE has a dividend in line with its industry peers.
CTRE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 4.26%

5.2 History

The dividend of CTRE has a limited annual growth rate of 5.26%.
CTRE has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of CTRE decreased in the last 3 years.
Dividend Growth(5Y)5.26%
Div Incr Years2
Div Non Decr Years2

5.3 Sustainability

CTRE pays out 156.68% of its income as dividend. This is not a sustainable payout ratio.
CTRE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP156.68%
EPS Next 2Y69.27%
EPS Next 3Y45.4%

CARETRUST REIT INC

NYSE:CTRE (12/20/2024, 8:04:21 PM)

After market: 27.5 +0.14 (+0.51%)

27.36

+0.15 (+0.55%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-29 2024-10-29/amc
Earnings (Next)02-06 2025-02-06/amc
Inst Owners96.38%
Inst Owner Change15.4%
Ins Owners0.47%
Ins Owner Change-2.36%
Market Cap5.12B
Analysts82.67
Price Target34.34 (25.51%)
Short Float %1.89%
Short Ratio1.64
Dividend
Industry RankSector Rank
Dividend Yield 4.26%
Dividend Growth(5Y)5.26%
DP156.68%
Div Incr Years2
Div Non Decr Years2
Ex-Date12-31 2024-12-31 (0.29)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-51.46%
Min EPS beat(2)-73.43%
Max EPS beat(2)-29.49%
EPS beat(4)0
Avg EPS beat(4)-31.51%
Min EPS beat(4)-73.43%
Max EPS beat(4)-9.38%
EPS beat(8)0
Avg EPS beat(8)-45.82%
EPS beat(12)1
Avg EPS beat(12)-40.75%
EPS beat(16)3
Avg EPS beat(16)-30.02%
Revenue beat(2)2
Avg Revenue beat(2)16.99%
Min Revenue beat(2)0.19%
Max Revenue beat(2)33.8%
Revenue beat(4)2
Avg Revenue beat(4)7.99%
Min Revenue beat(4)-1.16%
Max Revenue beat(4)33.8%
Revenue beat(8)5
Avg Revenue beat(8)5.09%
Revenue beat(12)7
Avg Revenue beat(12)3.05%
Revenue beat(16)8
Avg Revenue beat(16)2.01%
PT rev (1m)6.32%
PT rev (3m)16.99%
EPS NQ rev (1m)0%
EPS NQ rev (3m)16.42%
EPS NY rev (1m)-7.02%
EPS NY rev (3m)-9.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.98%
Revenue NY rev (1m)5.58%
Revenue NY rev (3m)6.28%
Valuation
Industry RankSector Rank
PE 38
Fwd PE 19.89
P/S 19.01
P/FCF N/A
P/OCF 24.17
P/B 2.11
P/tB 2.11
EV/EBITDA 22.29
EPS(TTM)0.72
EY2.63%
EPS(NY)1.38
Fwd EY5.03%
FCF(TTM)-0.52
FCFYN/A
OCF(TTM)1.13
OCFY4.14%
SpS1.44
BVpS12.95
TBVpS12.95
PEG (NY)0.49
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.38%
ROE 4.08%
ROCE 6.23%
ROIC 4.92%
ROICexc 5.68%
ROICexgc 5.68%
OM 65.34%
PM (TTM) 36.73%
GM 98.16%
FCFM N/A
ROA(3y)2.14%
ROA(5y)2.96%
ROE(3y)3.55%
ROE(5y)4.89%
ROIC(3y)5.48%
ROIC(5y)5.38%
ROICexc(3y)5.83%
ROICexc(5y)5.61%
ROICexgc(3y)5.83%
ROICexgc(5y)5.61%
ROCE(3y)6.94%
ROCE(5y)6.8%
ROICexcg growth 3Y2.68%
ROICexcg growth 5Y2.78%
ROICexc growth 3Y2.68%
ROICexc growth 5Y2.78%
OM growth 3Y1.9%
OM growth 5Y3.08%
PM growth 3Y-18.48%
PM growth 5Y-7.78%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA 1.72
Cap/Depr 564.92%
Cap/Sales 114.69%
Interest Coverage 5.59
Cash Conversion 91.87%
Profit Quality N/A
Current Ratio 4.14
Quick Ratio 4.14
Altman-Z 6.32
F-Score6
WACC8.66%
ROIC/WACC0.57
Cap/Depr(3y)298.03%
Cap/Depr(5y)342.19%
Cap/Sales(3y)76.85%
Cap/Sales(5y)97.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)75.61%
EPS 3Y-17.34%
EPS 5Y-7.79%
EPS Q2Q%162.5%
EPS Next Y77.44%
EPS Next 2Y69.27%
EPS Next 3Y45.4%
EPS Next 5YN/A
Revenue 1Y (TTM)28.22%
Revenue growth 3Y6.89%
Revenue growth 5Y6.78%
Sales Q2Q%38.48%
Revenue Next Year14.39%
Revenue Next 2Y18.33%
Revenue Next 3Y18.92%
Revenue Next 5YN/A
EBIT growth 1Y34.35%
EBIT growth 3Y8.92%
EBIT growth 5Y10.06%
EBIT Next Year94.37%
EBIT Next 3Y45.38%
EBIT Next 5Y29.83%
FCF growth 1Y-189.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.9%
OCF growth 3Y2.03%
OCF growth 5Y9.26%